The publisher Open Access Text (OAT) follows several of the same, questionable business practices as Hyderabad, India-based OMICS Group, leading me to suspect that it may have been acquired by OMICS. Currently in the middle of a massive spamming campaign, OAT uses the “my previous email” ploy, using emails to bait researchers with the promise of a fast peer review process. Read the rest of this entry »
Over the past couple weeks I’ve received several emails informing me about two scholarly publishers / conference organizers and their intentional use of duplicate or nearly-duplicate journal titles and conference names.
OMICS Group recently launched a new open-access journal called Diagnostic Pathology: Open Access. The title closely matches that of the BioMed Central (BMC) journal Diagnostic Pathology. It also matches the scope of The Diagnostic Pathology Journal, a new open-access journal launched by the former editor-in-chief of the BMC journal.
The Journal of Chest is a new medical journal published by the OMICS-Group-owned Insight Medical Publishing (ImedPub). The journal is competing in a sleazy way with the legitimate and respected medical journal CHEST, published since 1935 by the American College of Chest Physicians.
Hyderabad, India-based OMICS Group has found a new and likely lucrative revenue source — charging authors to withdraw their submissions to the publisher’s many journals.
The International Journal of Cardiovascular Research is a subscription journal published by the OMICS Group imprint called SciTechnol. This is a hybrid journal, meaning it’s a subscription journal with an option for authors to pay a fee and have the article made open access.
OMICS Group continues to launch and publish scholarly journals whose titles closely match those of established and respected journals, including journals published by scholarly societies. OMICS Group’s goal is to trick researchers into thinking the OMICS journals are actually the legitimate journals, so they can get the author fees from the authors.